FMTX - Forma Therapeutics Holdings' (FMTX) CEO Frank Lee on Q4 2021 Results - Earnings Call Transcript
Forma Therapeutics Holdings, Inc. (FMTX) Q4 2021 Earnings Conference Call March 1, 2022 8:00 AM ET Company Participants Mario Corso – Senior Director of Investor Relations Frank Lee – President and Chief Executive Officer Patrick Kelly – Senior Vice President, Chief Medical Officer Dave Cook – Senior Vice President, Chief Scientific Officer Todd Shegog – Senior Vice President, Chief Financial Officer Conference Call Participants Tiago Fauth – Credit Suisse Alethia Young – Cantor Fitzgerald Maury Raycroft – Jefferies Mark Breidenbach – Oppenheimer Andrew Berens – SVB Presentation Operator Welcome to the Forma Therapeutics Year End 2021 Financial Results and Business Update Conference Call. All participants are currently in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, March 1, 2022. Now, I like to turn the conference over to Mario Corso. Please go ahead. Mario
For further details see:
Forma Therapeutics Holdings' (FMTX) CEO Frank Lee on Q4 2021 Results - Earnings Call Transcript